Table 6: Blood pressure, body composition, CBC parameters, liver, and renal function.
|
Week 0 |
Week 4 |
Week 8 |
| SBP (mmHg) |
Placebo |
118.04 ± 12.79 |
114.81 ± 13.76 |
116.38 ± 16.10 |
| Active |
122.67 ± 16.40 |
117.93 ± 16.64 |
117.13 ± 14.77 |
| DBP (mmHg) |
Placebo |
73.93 ± 10.29 |
72.30 ± 9.85 |
71.92 ± 8.97 |
| Active |
74.80 ± 11.61 |
73.43 ± 10.57 |
73.27 ± 10.37 |
| BW (kg) |
Placebo |
56.75 ± 7.77 |
56.71 ± 7.89 |
56.63 ± 7.92 |
| Active |
58.56 ± 11.35 |
58.54 ± 11.36 |
58.53 ± 11.26 |
| BFP (%) |
Placebo |
27.82 ± 6.82 |
28.08 ± 5.81 |
27.53 ± 6.08 |
| Active |
30.12 ± 6.10 |
30.07 ± 6.66 |
30.19 ± 6.14 |
| BMI (kg/m2) |
Placebo |
22.05 ± 2.53 |
21.98 ± 2.57 |
21.95 ± 2.59 |
| Active |
23.42 ± 3.43 |
23.42 ± 3.43 |
23.41 ± 3.43 |
| WBC (×103/μl) |
Placebo |
5.27 ± 1.57 |
5.27 ± 1.45 |
5.03 ± 1.34 |
| Active |
5.33 ± 1.36 |
5.44 ± 1.28 |
5.18 ± 1.31 |
| RBC (×104/μl) |
Placebo |
449.00 ± 38.51 |
456.19 ± 50.98 |
445.12 ± 39.13 |
| Active |
466.50 ± 39.67 |
467.37 ± 43.99 |
468.63 ± 44.75 |
| Hb (g/dl) |
Placebo |
13.31 ± 1.13 |
13.50 ± 1.36 |
13.36 ± 1.07 |
| Active |
13.55 ± 1.29 |
13.50 ± 1.34 |
13.61 ± 1.31 |
| Ht (%) |
Placebo |
41.18 ± 3.37 |
41.66 ± 4.05 |
40.58 ± 3.44 |
| Active |
41.67 ± 3.37 |
41.79 ± 3.53 |
41.55 ± 3.33 |
| Plt (×104/μl) |
Placebo |
23.89 ± 4.93 |
25.72 ± 5.34 |
24.46 ± 4.52 |
| Active |
25.29 ± 4.70 |
25.58 ± 4.97 |
25.14 ± 5.03 |
| AST (U/l) |
Placebo |
23.36 ± 6.49 |
21.41 ± 4.25 |
21.35 ± 4.37 |
| Active |
21.33 ± 4.47 |
21.17 ± 4.19 |
20.60 ± 2.85 |
| ALT (U/l) |
Placebo |
23.36 ± 15.71 |
19.30 ± 7.97 |
18.42 ± 6.27 |
| Active |
19.03 ± 7.51 |
18.70 ± 7.66 |
17.93 ± 6.51 |
| γ-GTP (U/l) |
Placebo |
31.57 ± 36.30 |
24.11 ± 11.29 |
23.04 ± 11.50 |
| Active |
25.33 ± 16.32 |
25.53 ± 17.72 |
23.97 ± 15.18 |
| ALP (U/l) |
Placebo |
189.39 ± 78.94 |
183.41 ± 43.99 |
170.96 ± 39.28 |
| Active |
214.60 ± 52.88 |
218.40 ± 67.04 |
215.93 ± 67.69 |
| LDH (U/l) |
Placebo |
195.75 ± 30.79 |
194.93 ± 28.82 |
192.42 ± 32.37 |
| Active |
199.30 ± 30.86 |
198.57 ± 28.76 |
197.63 ± 26.49 |
| BUN (mg/dl) |
Placebo |
15.19 ± 4.41 |
15.29 ± 4.37 |
14.69 ± 4.75 |
| Active |
13.48 ± 2.69 |
14.13 ± 3.16 |
13.39 ± 2.68 |
| CRE (mg/dl) |
Placebo |
0.76 ± 0.12 |
0.77 ± 0.11 |
0.74 ± 0.12 |
| Active |
0.73 ± 0.13 |
0.72 ± 0.13 |
0.72 ± 0.14 |
| UA (mg/dl) |
Placebo |
4.71 ± 1.14 |
5.00 ± 1.25 |
4.75 ± 1.26 |
| Active |
4.93 ± 0.95 |
5.05 ± 1.02 |
4.91 ± 1.00 |
Values are shown as means ± standard deviations. Abbreviations: Alanine Aminotransferase (ALT), Alkaline Phosphatase (ALP), Aspartate Aminotransferase (AST), Blood Urea Nitrogen (BUN), Body Fat Percentage (BFP), Body Mass Index (BMI), Body Weight (BW), Complete Blood Counts (CBCs), Creatinine (CRE), Diastolic Blood Pressure (DBP), Gamma Glutamyl Transpeptidase (γ-GTP), Hematocrit (Ht), Hemoglobin (Hb), Lactate Dehydrogenase (LDH), Platelet (Plt), Red Blood Cells (RBC), Systolic Blood Pressure (SBP), Uric Acid (UA), White Blood Cells (WBC)